CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+4.05%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$8B
AUM Growth
+$186M
(+2.4%)
Cap. Flow
-$856M
Cap. Flow
% of AUM
-10.7%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
870
New
73
Increased
308
Reduced
302
Closed
63
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$50.9M |
| 2 |
Procter & Gamble
PG
|
$26.1M |
| 3 |
Keysight
KEYS
|
$24.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$22.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
$20.5M |
Top Sells
| 1 |
ManpowerGroup
MAN
|
$744M |
| 2 |
CELG
Celgene Corp
CELG
|
$45.1M |
| 3 |
Exxon Mobil
XOM
|
$36.1M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$28.3M |
| 5 |
Walt Disney
DIS
|
$26.8M |
Sector Composition
| 1 | Healthcare | 33.22% |
| 2 | Technology | 16.94% |
| 3 | Financials | 10.4% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Diamondback Energy
FANG
$40.2B
| $4.8M | 0.06% |
44,242
-49,620
| -53% | -$5.38M |
|
327
AvalonBay Communities
AVB
$27.8B
| $4.8M | 0.06% |
14,683
+3,080
| +27% | +$1.01M |
|
328
Toyota
TM
$260B
| $4.71M | 0.06% |
38
| – | – |
|
|
NATI
329
DELISTED
National Instruments Corp
NATI
| $4.68M | 0.06% |
111,836
-28,940
| -21% | -$1.21M |
|
330
General Motors
GM
$55.5B
| $4.62M | 0.06% |
120,427
-1,490
| -1% | -$57.2K |
|
331
Zoetis
ZTS
$67.9B
| $4.62M | 0.06% |
40,876
-1,337
| -3% | -$151K |
|
|
AQ
332
DELISTED
Aquantia Corp. Common Stock
AQ
| $4.61M | 0.06% |
+355,454
| New | +$4.61M |
|
333
Kellanova
K
$27.8B
| $4.61M | 0.06% |
92,025
-4,186
| -4% | -$210K |
|
334
Phillips 66
PSX
$53.2B
| $4.6M | 0.06% |
49,364
-10,186
| -17% | -$949K |
|
335
National Fuel Gas
NFG
$7.82B
| $4.59M | 0.06% |
87,316
+20,695
| +31% | +$1.09M |
|
336
Church & Dwight Co
CHD
$23.3B
| $4.58M | 0.06% |
62,918
+11,376
| +22% | +$828K |
|
337
Parker-Hannifin
PH
$96.1B
| $4.55M | 0.06% |
26,884
+5,307
| +25% | +$898K |
|
338
Theravance Biopharma
TBPH
$703M
| $4.55M | 0.06% |
279,700
| – | – |
|
339
KeyCorp
KEY
$20.8B
| $4.52M | 0.06% |
255,893
-8,615
| -3% | -$152K |
|
340
Capri Holdings
CPRI
$2.53B
| $4.52M | 0.06% |
130,939
+52,307
| +67% | +$1.81M |
|
341
Cummins
CMI
$55.1B
| $4.51M | 0.06% |
26,434
-7,229
| -21% | -$1.23M |
|
342
Edwards Lifesciences
EW
$47.5B
| $4.49M | 0.06% |
73,287
+2,478
| +3% | +$152K |
|
343
Boston Scientific
BSX
$159B
| $4.46M | 0.06% |
104,242
-5,851
| -5% | -$250K |
|
344
Sangamo Therapeutics
SGMO
$165M
| $4.45M | 0.06% |
+415,000
| New | +$4.45M |
|
|
WRK
345
DELISTED
WestRock Company
WRK
| $4.39M | 0.05% |
120,762
-1,210
| -1% | -$43.9K |
|
|
CXO
346
DELISTED
CONCHO RESOURCES INC.
CXO
| $4.36M | 0.05% |
42,433
-891
| -2% | -$91.5K |
|
|
MRO
347
DELISTED
Marathon Oil Corporation
MRO
| $4.33M | 0.05% |
306,259
-286,877
| -48% | -$4.06M |
|
348
Interpublic Group of Companies
IPG
$9.94B
| $4.33M | 0.05% |
192,517
-238,714
| -55% | -$5.37M |
|
349
Madrigal Pharmaceuticals
MDGL
$9.65B
| $4.33M | 0.05% |
41,450
| – | – |
|
350
International Paper
IP
$25.7B
| $4.29M | 0.05% |
78,575
-13,038
| -14% | -$712K |
|